On the other hand, Moderna Inc (NASDAQ: MRNA) posted a surprise profit and higher than expected revenue following the launch ...

When CVS Health (CVS) jumped, trading above $60, the rally did not last. Markets initially responded well to CVS’s Q3 results ...

The "North America RNA Therapeutics Market, By Country, Competition, Forecast & Opportunities, 2019-2029F" report has been ...

However, Covid vaccines are another issue Trump - who spearheaded the production of Moderna and Pfizer shots - may be ...

Arbutus has moved into Part 3 of this clinical trial which evaluates repeat dosing of AB-101 for 28 days in patients with cHBV and expects to report preliminary data in the first half of next year.

In this article, we will discuss the 12 High Growth Large Cap Stocks to Buy Now. BlackRock highlighted that its portfolio ...

The company has discontinued the Phase I/II trial of its only clinical candidate due to a potential “unfavourable ...

Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...

A business that has been around for more than 30 years is closing its doors in Portsmouth. The owner of C.H. Smith Appliances ...

Contact Varga at [email protected] Pfizer is about twice as accessible in some southeastern local government areas than in regions in Melbourne’s north and west that have suffered the highest ...

Trump Taps Matt Gaetz for Attorney General, a Provocative Move President-elect Trump plans to nominate the Florida congressman, among a flurry of personnel announcements as Republicans neared ...

Former Democratic congresswoman Tulsi Gabbard has been appointed as the director of national intelligence by US President-elect Donald Trump. Gabbard, who switched to the Republican Party, is a ...